Out of the 21 cases with lymph node metastasis, high EZH2 immunoexpression was found in 20 (20/21, 95.23%) cases and low immunoexpression in only one case (1/21, 4.7%) (Table 2). Here, EZH2 is linked to metastatic malignant neoplasm in the lymph nodes.